You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 4, January 27, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  US Preventive Services Task Force
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Occult Blood Screening for Colorectal Cancer

Kevin K. Knight, MD, MPH; Jonathan E. Fielding, MD, MPH; Renaldo N. Battista, MD, ScD

JAMA. 1989;261(4):586-593.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

GENERAL BACKGROUND

Colorectal cancer has long been the target of efforts aimed at early detection. It is the second most common cancer in the United States, with 140 000 new cases and 60 000 deaths estimated to have occurred in 1987.1 It is uncommon in persons younger than 50 years but its incidence increases sharply thereafter.2 Investigations into the causes of colorectal cancer have not yielded a consensus strategy for prevention. However, early treatment generally is acknowledged to be more beneficial than late treatment. Early detection would thus seem to be a reasonable approach to lowering the toll of this cancer.

The American Cancer Society and the National Cancer Institute recommend yearly occult blood testing for all persons older than 50 years of age.3,4 The Canadian Task Force on the Periodic Health Examination has recommended the use of fecal occult blood testing by asymptomatic persons older than . . . [Full Text PDF of this Article]


Author Affiliations

From the Schools of Public Health (Drs Knight and Fielding) and Medicine (Dr Fielding), University of California at Los Angeles; Johnson & Johnson Health Management Inc, Santa Monica, Calif (Drs Knight and Fielding); and the Department of Medicine, the Division of Clinical Epidemiology, Montreal General Hospital (Dr Battista).


Footnotes

Reprint requests to Johnson & Johnson Health Management Inc, 2825 Santa Monica Blvd, Santa Monica, Calif 90404 (Dr Fielding).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.